Anti-CING/ CGN monoclonal antibody

Anti-CING/ CGN antibody for FACS & in-vivo assay

Target products collectionGo to CGN/CGN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP0256-Ab-1/ GM-Tg-hg-MP0256-Ab-2Anti-Human CGN monoclonal antibodyHuman
GM-Tg-rg-MP0256-Ab-1/ GM-Tg-rg-MP0256-Ab-2Anti-Rat CGN monoclonal antibodyRat
GM-Tg-mg-MP0256-Ab-1/ GM-Tg-mg-MP0256-Ab-2Anti-Mouse CGN monoclonal antibodyMouse
GM-Tg-cynog-MP0256-Ab-1/ GM-Tg-cynog-MP0256-Ab-2Anti-Cynomolgus/ Rhesus macaque CGN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP0256-Ab-1/ GM-Tg-felg-MP0256-Ab-2Anti-Feline CGN monoclonal antibodyFeline
GM-Tg-cang-MP0256-Ab-1/ GM-Tg-cang-MP0256-Ab-2Anti-Canine CGN monoclonal antibodyCanine
GM-Tg-bovg-MP0256-Ab-1/ GM-Tg-bovg-MP0256-Ab-2Anti-Bovine CGN monoclonal antibodyBovine
GM-Tg-equg-MP0256-Ab-1/ GM-Tg-equg-MP0256-Ab-2Anti-Equine CGN monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP0256-Ab-1/ GM-Tg-hg-MP0256-Ab-2; GM-Tg-rg-MP0256-Ab-1/ GM-Tg-rg-MP0256-Ab-2;
GM-Tg-mg-MP0256-Ab-1/ GM-Tg-mg-MP0256-Ab-2; GM-Tg-cynog-MP0256-Ab-1/ GM-Tg-cynog-MP0256-Ab-2;
GM-Tg-felg-MP0256-Ab-1/ GM-Tg-felg-MP0256-Ab-2; GM-Tg-cang-MP0256-Ab-1/ GM-Tg-cang-MP0256-Ab-2;
GM-Tg-bovg-MP0256-Ab-1/ GM-Tg-bovg-MP0256-Ab-2; GM-Tg-equg-MP0256-Ab-1/ GM-Tg-equg-MP0256-Ab-2
Products NameAnti-CGN monoclonal antibody
Formatmab
Target NameCGN
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CGN benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species CING/ CGN VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP0256
    Target NameCGN
    Gene ID57530,70737,310655,710830,483198,101100990,533725,100059886
    Gene Symbol and Synonyms6330408J11Rik,CGN
    Uniprot AccessionQ9P2M7,A7YH32
    Uniprot Entry NameCING_HUMAN,CING_CANLF
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000143375
    Target ClassificationN/A

    The target: CGN, gene name: CGN, also named as . Enables cadherin binding activity. Predicted to act upstream of or within bicellular tight junction assembly; epithelial cell morphogenesis; and microtubule cytoskeleton organization. Located in bicellular tight junction and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.